MX367150B - Partículas de rotavirus con proteínas de superficie quiméricas. - Google Patents
Partículas de rotavirus con proteínas de superficie quiméricas.Info
- Publication number
- MX367150B MX367150B MX2016000075A MX2016000075A MX367150B MX 367150 B MX367150 B MX 367150B MX 2016000075 A MX2016000075 A MX 2016000075A MX 2016000075 A MX2016000075 A MX 2016000075A MX 367150 B MX367150 B MX 367150B
- Authority
- MX
- Mexico
- Prior art keywords
- rotavirus particles
- surface proteins
- chimeric surface
- relates
- particles
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/14—Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12323—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12351—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13175637 | 2013-07-08 | ||
| PCT/EP2014/064652 WO2015004158A1 (en) | 2013-07-08 | 2014-07-08 | Rotavirus particles with chimeric surface proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016000075A MX2016000075A (es) | 2016-07-19 |
| MX367150B true MX367150B (es) | 2019-08-07 |
Family
ID=48747990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000075A MX367150B (es) | 2013-07-08 | 2014-07-08 | Partículas de rotavirus con proteínas de superficie quiméricas. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10192025B2 (enExample) |
| EP (1) | EP3019518B1 (enExample) |
| JP (1) | JP6594306B2 (enExample) |
| CN (1) | CN105518022B (enExample) |
| AU (1) | AU2014289274B2 (enExample) |
| CA (1) | CA2916827C (enExample) |
| ES (1) | ES2733279T3 (enExample) |
| MX (1) | MX367150B (enExample) |
| RU (1) | RU2698049C2 (enExample) |
| WO (1) | WO2015004158A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202000101T1 (it) * | 2008-10-10 | 2020-03-13 | Childrens Medical Center | Vaccino con trimero di env di hiv-1 stabilizzato biochimicamente |
| CN105263506B (zh) | 2013-01-07 | 2018-03-09 | 贝丝以色列女执事医疗中心 | 稳定的人免疫缺陷病毒(HIV)包膜(EnV)三聚体疫苗及其使用方法 |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| WO2017071713A1 (en) * | 2015-10-30 | 2017-05-04 | University Of Copenhagen | Virus like particle with efficient epitope display |
| MA44418B1 (fr) * | 2017-03-02 | 2021-11-30 | Intelligent Virus Imaging Inc | Procédé permettant la mesure quantitative de contenu particulaire à l'aide d'une imagerie à l'état hydraté |
| CN109627295B (zh) * | 2018-12-29 | 2020-08-04 | 四川大学 | 一种通用型狂犬病相关病毒g蛋白胞外段的制备方法 |
| CN110144334B (zh) * | 2019-05-05 | 2021-03-16 | 中国水产科学研究院长江水产研究所 | 一种共表达草鱼呼肠孤病毒外衣壳蛋白vp4和vp35的重组杆状病毒的制备方法和应用 |
| CN110408637B (zh) * | 2019-08-08 | 2020-12-25 | 中国水产科学研究院长江水产研究所 | 一种草鱼出血病酵母口服疫苗及应用 |
| CN114316009B (zh) * | 2020-09-29 | 2023-04-25 | 上海交通大学 | 一种能够结合多种病毒的蛋白及其应用 |
| CN115044597A (zh) * | 2022-07-22 | 2022-09-13 | 态创生物科技(广州)有限公司 | 基于噬菌体展示和蛋白酶切割的寡肽表达和提纯方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0235754A2 (en) | 1986-03-04 | 1987-09-09 | Abbott Laboratories | Composition and methods of use for a lacZ rotavirus fusion protein |
| JP3055687B2 (ja) * | 1987-08-10 | 2000-06-26 | ザ ユニバーシティー オブ メルボルン | Ｖｐ７をコードするヒトロタウイルス血清型４遺伝子９の分子クローニング、糖タンパク質特異的主要外部カプシド中和及びワクチンに使用するためのｖｐ７及びそのフラグメントの発現 |
| ZA929418B (en) * | 1991-12-06 | 1993-06-07 | Whitehead Biomedical Inst | Recombinant vaccines and method of producing same. |
| WO2006007555A2 (en) * | 2004-07-01 | 2006-01-19 | Children's Medical Center Corporation ¨ | Rotavirus antigens |
| US7655439B2 (en) | 2005-09-09 | 2010-02-02 | Zymogenetics, Inc. | Trimerizing polypeptides |
| KR101502619B1 (ko) * | 2007-03-29 | 2015-03-16 | 한국엠에스디 유한회사 | 인간로타바이러스의 ｖｐ７ 유전자 및 이에 특이적인프라이머 또는 프로브를 포함하는 인간로타바이러스 감염증진단용 조성물 |
| CN102465137B (zh) * | 2010-11-05 | 2014-03-12 | 上海生物制品研究所有限责任公司 | 表达轮状病毒类表达颗粒的毕赤酵母、其制备方法及用途 |
-
2014
- 2014-07-08 AU AU2014289274A patent/AU2014289274B2/en active Active
- 2014-07-08 ES ES14736835T patent/ES2733279T3/es active Active
- 2014-07-08 CA CA2916827A patent/CA2916827C/en active Active
- 2014-07-08 JP JP2016524801A patent/JP6594306B2/ja active Active
- 2014-07-08 WO PCT/EP2014/064652 patent/WO2015004158A1/en not_active Ceased
- 2014-07-08 EP EP14736835.1A patent/EP3019518B1/en active Active
- 2014-07-08 CN CN201480049500.2A patent/CN105518022B/zh active Active
- 2014-07-08 MX MX2016000075A patent/MX367150B/es active IP Right Grant
- 2014-07-08 RU RU2016103770A patent/RU2698049C2/ru active
- 2014-07-08 US US14/900,829 patent/US10192025B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015004158A1 (en) | 2015-01-15 |
| JP6594306B2 (ja) | 2019-10-23 |
| US20160188790A1 (en) | 2016-06-30 |
| JP2016530236A (ja) | 2016-09-29 |
| RU2698049C2 (ru) | 2019-08-21 |
| CN105518022A (zh) | 2016-04-20 |
| RU2016103770A3 (enExample) | 2018-07-25 |
| MX2016000075A (es) | 2016-07-19 |
| RU2016103770A (ru) | 2017-08-11 |
| EP3019518A1 (en) | 2016-05-18 |
| US10192025B2 (en) | 2019-01-29 |
| EP3019518B1 (en) | 2019-04-03 |
| CN105518022B (zh) | 2020-08-18 |
| AU2014289274B2 (en) | 2018-11-15 |
| ES2733279T3 (es) | 2019-11-28 |
| CA2916827C (en) | 2021-11-02 |
| AU2014289274A1 (en) | 2016-02-18 |
| CA2916827A1 (en) | 2015-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX367150B (es) | Partículas de rotavirus con proteínas de superficie quiméricas. | |
| JO3772B1 (ar) | صيغة جسم مضاد لـ cgrp | |
| EP4324473A3 (en) | Multiparametric nucleic acid optimization | |
| PH12017501115A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and method of use | |
| MX2019013670A (es) | Formulaciones de anticuerpos y proteinas. | |
| MX2016011641A (es) | Procedimiento de preparacion de proteinas plasmaticas humanas. | |
| PH12015500196A1 (en) | Methods of treating a tauopathy | |
| EP3094653A4 (en) | Chimeric antigen receptors (cars) having mutations in the fc spacer region and methods for their use | |
| SG11201509447YA (en) | Ophthalmic nanoemulsion composition containing cyclosporine and method for preparing same | |
| MY195289A (en) | Anti IL-36R Antibodies | |
| TN2014000438A1 (en) | Anti-fcrn antibodies | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| MY186864A (en) | Fusion immunomodulatory proteins and methods for making same | |
| PH12016500753A1 (en) | Antibodies specific to fcrn | |
| MX2017014397A (es) | Anticuerpos anti-receptor neonatal de fragmento cristalizable(fcrn). | |
| MX2019015604A (es) | Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia. | |
| CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
| TN2014000498A1 (en) | Pharmaceutical formulation | |
| ZA201801498B (en) | An improved refolding process for antibody's fragments | |
| EP3057928A4 (en) | Process for producing 1-chloro-3,3,3-trifluoropropene in an ionic liquid | |
| MX2024000004A (es) | Proteinas de fusion de inhibidor de tripsina urinaria (uti). | |
| MX2016014726A (es) | Proteinas de union al antigeno her1 que se unen a la beta-horquilla de her1. | |
| MY195395A (en) | Fusion Immunomodulatory Proteins and Methods for Making Same | |
| HUP1500443A2 (en) | Improved tissue culture method for the elimination of viruses in grapevine | |
| PL3115053T3 (pl) | Sposób otrzymywania preparatu białka pęcherzykowego i preparat otrzymany za pomocą tego sposobu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |